Pharmaceutical trademarks
Inconsistencies in approach to the test oflikelihood of confusion make it difficultto evaluate in advance the risks associatedwith adopting a pharmaceuticaltrademark in Italy.
Download
-
-
News & Analysis
-
-
- Categories
- News & Analysis
- Legal Updates
- Long Reads
- Opinion
-
-
- Reports
- Data & Tools
-
Rankings
-
-
- WTR 1000
- Introduction
- All firms
- All individuals
-
- WTR 300
- Introduction
- Individual rankings
-
- Law firm leaders
- EUIPO Filing Elite
- The Global IP Awards
- WTR Global Leaders
-
- WTR Analytics
- WTR 1000 Analytics
-
-
-
Insight
-
-
- Insight
- Guides
- Reviews
- Market Insight
-
-
-
Events
-
-
- Events
- WTR Events
- Diary
-
-
-
- Login | Register